CRISPR Therapeutics Plans First CRISPR/Cas9 Clinical Trial in Europe for 2018 – Labiotech.eu (blog)
Labiotech.eu (blog) |
CRISPR Therapeutics Plans First CRISPR/Cas9 Clinical Trial in Europe for 2018
Labiotech.eu (blog) CRISPR Therapeutics and Vertex Pharmaceuticals are taking action to start a first clinical trial with CRISPR/Cas9 in Europe in 2018. The blood disorder β-thalassemia could soon be the first human disease to be treated using CRISPR/Cas9 technology in … Technical Views: Tracking the Numbers on Shares of Crispr Therapeutics Ag (CRSP) |
